Stock PROC PROCAPS GROUP S.A.
Add to a list
To use this feature you must be a member
Log inSign up

News Procaps Group S.A.

Equities

PROC

LU2376511205

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-05-01 pm EDT 		5-day change 1st Jan Change
2.775 USD +5.92% Intraday chart for Procaps Group S.A. +0.91% -31.82%
Mar. 04 Procaps Group S.A. Announces Formation of Strategic Committee to Explore Value Creation Alternatives CI
Mar. 04 Procaps Group Announces Formation of Strategic Committee to Explore Value Creation Alternatives CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Procaps Group Delays Filing of Annual Report on Form 20-F
BU
Procaps Announces Formation of Strategic Committee to Explore Value Creation Alternatives
BU
Procaps Group S.A. Announces Formation of Strategic Committee to Explore Value Creation Alternatives
CI
Procaps Group Announces Formation of Strategic Committee to Explore Value Creation Alternatives
CI
Hoche Partners Pharma Holding S A Issues a Letter to Procaps Group, S A
CI
Procaps Issues Shareholder Letter from New CEO
BU
Declaration of Voting Results by Procaps Group, S A
CI
Procaps Group – Notice to Shareholders
BU
Hoche Partners Sends a Letter to Procaps Group
CI
Procaps Group Reports Third Quarter 2023 Results
BU
Procaps Group S.A. Provides Earnings Guidance for the Full Year 2023
CI
Procaps S A : and subsidiaries (The Group) - Form 6-K
PU
Procaps S A : Group Reports Third Quarter 2023 Results - Form 6-K
PU
Procaps Group S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Tranche Update on Procaps Group S.A.'s Equity Buyback Plan announced on June 1, 2023.
CI
Statement from the Board of Directors of Procaps Group
BU
Procaps Group Teams Up With Genomma Lab to Manufacture, Market Softgel Products in Latin America
MT
Procaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture and Market Softgel Products in Latin America
PR
Procaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture and Market Softgel Products in Latin America
BU
Procaps Group and Genomma Lab Announce Strategic Agreement to Manufacture and Market Softgel Products in Latin America
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PROC Stock
  4. News Procaps Group S.A.